اخبار و اعلانات
آمار
| تعداد نشریات | 20 |
| تعداد شماره‌ها | 508 |
| تعداد مقالات | 4,388 |
| تعداد مشاهده مقاله | 8,220,056 |
| تعداد دریافت فایل اصل مقاله | 4,214,940 |
عملکرد راهبرد تجاریسازی خرید و ادغام؛ طراحی و تبیین الگو در صنعت داروهای زیستی ایران | ||
| اندیشه مدیریت راهبردی | ||
| مقاله 8، دوره 15، شماره 2 - شماره پیاپی 30، مهر 1400، صفحه 237-270 اصل مقاله (557.29 K) | ||
| نوع مقاله: مقاله علمی-پژوهشی | ||
| شناسه دیجیتال (DOI): 10.30497/smt.2022.241351.3267 | ||
| نویسنده | ||
| رؤیا شاکری* | ||
| استادیار گروه مدیریت، دانشکده علوم انسانی، واحد سنندج، دانشگاه آزاد اسلامی، سنندج، ایران. | ||
| چکیده | ||
| زیستفناوری پزشکی یا درمانی به توسعه ابزارهای تحقیقاتی، تشخیص، توسعه و تحویل داروها و واکسنها از طریق استفاده از سیستمها یا فرآیندهای سلولی و مولکولهای زیستی اختصاص دارد. یک انتخاب راهبردی بسیار مهم بنگاههای فناوریمحور در صنعت داروهای زیستی، راهبرد تجاریسازی است. راهبرد خرید و ادغام بهعنوان یکی از راهبردهای تجاریسازی داروهای زیستی در مقایسه با دیگر راهبردها کمتر در ادبیات پژوهش مورد توجه و تدقیق واقع شده است. هدف پژوهش حاضر، طراحی مدل جامع راهبرد تجاریسازی خرید و ادغام در صنعت داروهای زیستی کشور برمبنای رویکرد آمیخته متوالی کیفی ـ کمی است. برای تحلیل ادبیات پژوهش از روش فراترکیب و برای اعتبارسنجی محتوایی مدل پیشنهادی از تکنیک مدلسازی گروهی برمبنای نظر خبرگان و در بخش کمی براساس راهبرد پیمایش و از تکنیک حداقل مربعات جزئی استفاده شده است. نتایج نشان داد از بین هفت مقوله پیشبین شامل؛ مکمل بودن منابع، عدم تقارن اطلاعاتی، تجربه ائتلاف بین خریدار و شرکت خریداریشده، تجربه خرید مرتبط، نزدیکی فرهنگی، جغرافیایی، و کسبوکار، انتقال دانش و منابع (کارکردی، عملیاتی و مدیریتی) و فرآیند یکپارچگی و مقوله عملکرد بهعنوان پیآمد این راهبرد، در صنعت داروهای زیستی کشور تنها مقوله مکملبودن منابع برای شرکتهای فعال در این صنعت بهعنوان عامل پیشبین مطرح است. | ||
| کلیدواژه‌ها | ||
| راهبرد تجاریسازی خرید و ادغام؛ فراترکیب؛ مدلسازی گروهی؛ صنعت داروهای زیستی؛ ایران | ||
| عنوان مقاله [English] | ||
| Performance of commercialization strategy, acquisition and merger; Design and explanation of model in Iranian biopharmaceutical industry | ||
| نویسندگان [English] | ||
| roya shakeri | ||
| Assistant Professor, Department of Management, Faculty of Humanities, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran. | ||
| چکیده [English] | ||
| Medical or therapeutic biotechnology is the development of research tools, the diagnosis, development and delivery of drugs and vaccines through the use of cellular systems or processes and biological molecules. A very important strategic choice of technology-oriented enterprises in the biopharmaceutical industry is the commercialization strategy. The strategy of purchasing and merging as one of the strategies for commercialization and biomedical drugs has been less considered and researched in the research literature than other strategies. The purpose of this study is to design a comprehensive model of commercialization strategy, merge and acquisition in the country's biopharmaceutical industry based on a consecutive qualitative-quantitative mixed approach. To analyze the research literature, the meta synthesis method and to content validation of the proposed model, the group modeling technique based on the opinion of experts and in a small part based on the survey strategy and the partial least squares technique have been used. The results showed that among the seven categories of predictors, including; Resource complementarity, information asymmetry, experience of alliance between buyer and purchased company, related purchasing experience, cultural, geographical, and business proximity, knowledge and resource transfer (functional, operational, and managerial) and integration process and performance category as The consequence of this strategy, in the bio-pharmaceutical industry of the country, the only issue is the complementarity of resources for companies active in this industry as a predictor. | ||
| کلیدواژه‌ها [English] | ||
| Commercialization Strategy, merge and acquisition, Meta synthesis, Group Modeling, Biopharmaceutical Industry, Iran | ||
| مراجع | ||
|
رادفر، رضا؛ پیلهوری، نازنین؛ قاضی نوری، سید سپهر و شاکری، رؤیا (1394). مطالعه پیشرانههای قابلیت ائتلاف راهبردک در سطح بنگاه؛ مورد صنعت زیست دارویی. پژوهشهای مدیریت عمومی. 8 (27). صص. 45-70.
Acur, N., Kandemir, D., Weerd-Nederhof, P.C.D., Song, M. (2010). “Exploring the Impact of Technological Competence Development on Speed and NPD Program Performance”. journal of production innovation management. 27 (6). 915-929.
Ahuja, G. and R. Katila, (2001). “Technological acquisitions and the innovation performance of acquiring firms: A longitudinal study”. Strategic Management Journal. 22 (3). 197-220.
Alvarez, S. A. and J. B. Barney, (2002). “Resource-based theory and the entrepreneurial firm”. In M. A. Hitt, R. D. Ireland, S. M. Camp and D. L. Sexton (eds.), Strategic entrepreneurship: Creating a new mindset. Oxford: Basil Blackwell. 89-105.
Anand, B. N. and Khanna, T. (2000). Do firms learn to create value: the case of alliances. Strategic Management Journal. 21 (3). 295-315.
Arend, R. J. (2004). Conditions for asymmetric information solutions when alliances provide acquisition options and due diligence. Journal of Economics. 82 (3). 281-312.
Atkinson, S. (2019). Membrion raises funding to put it on the path to commercialisation in 2019. Membrane Technology. 2019 (1). Page 7.
Barron, O. E., Byard, D., Kile, C. and Riedl, E. J. (2002). High-technology intangibles and analysts’ forecasts. Journal of Accounting Research. 40 (2). 289-312.
Birkinshaw, J., H. Bresman and L. Håkanson, (2000). “Managing the post-acquisition integration process: how the human integration and task integration processes interact to foster value creation”. Journal of Management Studies. 37 (3). 395-425.
Björkman, I. K., G. Stahl and E. Vaara, (2007). “Cultural differences and capability transfer in cross-border acquisitions: The mediating roles of capability complementarity, absorptive capacity, and social integration”. Journal of International Business Studies. 38 (4). 658-672.
Bresman, H., Birkinshaw, J., & Nobel, R. (1999). Knowledge transfer in international acquisitions. Journal of International Business Studies. 30 (3). 439-462.
Caerteling, J.S., Halman, J.I.M., Dore´e, A.D. (2008). “Technology Commercialization in Road Infrastructure: How Government Affects the Variation and Appropriability of Technology”. journal of production innovation management. 25 (2). 143–161.
Capron, L. (1999). The long-term performance of horizontal acquisitions. Strategic Management Journal. 20 (11). 987– 1018.
Cartwright, S. and Cooper, C.L. (2016). Managing Mergers, Acquisitions, and Strategic Alliances: Integrating People and Cultures. 2nd ed. Butterworth & Heinemann. Oxford.
Chang, S.C., Tsai, M.T. (2013). “The effect of prior alliance experience on acquisition performance”. Applied Economics. 45 (6). 765–773.
Cheng, Y. (2019). "Integration duration of post-merger and leverage dynamics of mergers: theory and evidence". Pacific Accounting Review.
Child, J., Yan, Y. (2003). “Predicting the Performance of International Joint Ventures: An Investigation in China”. Journal of Management Studies. 40 (2). 283-320.
Cooke, F. L., (2006). “Acquisitions of Chinese state-owned enterprises by multinational corporations: Driving forces, barriers and implications for HRM”. British Journal of Management. 17 (1). 105-121.
Deng, P. (2010). “What Determines Performance of Cross-Border M&As by Chinese Companies? An Absorptive Capacity Perspective”. Thunderbird International Business Review. 52 (6). 509-524.
Etzkowitz, H. & Leydesdorff, L. (2000). “The dynamics of innovation: From National Systems and Mode 2 to a Triple Helix of university–industry–government relations”. Research Policy. 29 (2). 109–123.
Favre-Bonté, V., Thévenard-Puthod, C. (2013). “Resource and Skill Transfers in Subcontractor SME Acquisitions: Influence on the Long-Term Performance of Acquired Firms”. European Management Review. 10 (1). 117–135.
Feroz, E.H., Kim, S., Raab, R. (2005). Performance Measurement in Corporate Governance: DoMergers Improve Managerial Performance in the Post‐MergerPeriod? Review of Accounting and Finance. 4 (3). 86-101.
Finfgeld Connett, D. (2006). Meta synthesis of presence in nursing. Journal of Advanced Nursing. 55 (6). 708-714.
Finkelstein, S., Haleblian, J. (2002). “Understanding Acquisition Performance: The Role of Transfer Effects”. organization science. 13 (1). 36-47.
Frishammar, J., Lichtenthaler, U., Rundquist, J. (2012). “Identifying Technology Commercialization Opportunities: The Importance of Integrating Product Development Knowledge”. innovation management. 29 (4). 573–589.
Gans, J. S., Stern, S. (2003). “The product market and the market for “ideas”: commercialization strategies for technology entrepreneurs”. Research Policy, 32 (2). 333-350.
George, G., Zahra, S, A., Wheatley, K.K., Khan, R. (2001). “The effects of alliance portfolio characteristics and absorptive capacity on performance A study of biotechnology firms”. Journal of high technology management research. 12 (2). 205-226.
Gonçalves, F. R, Gonçalves, V. D. C (2008). “Strategic alliances and competitive performance in the pharmaceutical industry”. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing. 8 (1). 69-76.
Grant, R. M., (1991). “The resource-based theory of competitive advantage: Implications for strategy formulation”. California Management Review. 33 (3). 114-135.
Gulati, R., Lavie, D., Singh, H. (2009). “the nature of partnering experience and the gains from alliances". Strategic Management Journal. 30 (11). 1213-1233.
Haspeslagh, P. C. and D. B. Jemison, (1991). Managing acquisitions: Creating value through corporate renewal. NewYork: The Free Press.
Heimeriks, K.H., Duysters, G. (2007). Alliance Capability as a Mediator Between Experience and Alliance Performance: An Empirical Investigation into the Alliance Capability Development Process. Journal of Management Studies. 44 (1). 25-49.
Heinonen, L., and Sandberg, B. (2008). Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers. Journal of Commercial Biotechnology. 14 (4). 287-298
Huang, J., Pierce, J.R. and Tsyplakov, S. (2015). “Post-merger integration duration and leverage dynamics of mergers: theory and evidence 4”. working paper.
Insead, H.H., Rothaermel, F.T. (2005). "The effect of general and partner-specific alliance experience on joint R&D project performance". Academy of Management Journal. 48 (2). 332-345.
Kebriaeezadeh, A., Nassiri Koopaei, N., Abdollahiasl, A., Nikfar, SH., Mohamadi, N. (2013). Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries. DARU Journal of Pharmaceutical Sciences. 21(1). 52–. doi:10.1186/2008-2231-21-52
Kim, J. (2011). Alliance governance and technological performance: some evidence from biotechnology alliances. Industrial and Corporate Change. 20 (4). 969–990.
Kraaijenbrink, J., J.C. Spender and A. J. Groen, (2010). “The resource-based view: A review and assessment of its critiques”. Journal of Management. 36 (1). 349–372.
Larsson, R. and S. Finkelstein, (1999). “Integrating strategic, organizational, and human resource perspectives on mergers and acquisitions: A case survey of synergy realization”. Organization Science. 10 (1). 1–26.
Lawshe, C.H. (1975). “A quantitative approach to content validity”. Personnel Psychology. 28 (4). 563-575.
Lerner, J., and Merges, R.P. (1998). "the control of technology alliances: an empirical analysis of the biotechnology industry". the journal of industrial economics. 6 (2). 125-156.
Lin, Z., Yang, H., and Arya, B. (2009). “Alliance partners and firm performance: resource complementarity and status association". Strategic Management Journal. 30 (9). 921–940.
Lo, C. C., Wang, C. H., Chien, P. Y., Hung, C. W, (2012). “An empirical study of commercialization performance on Nano-products”. Technovation. 32. 168–178.
Mahima Thakur, M., Bansal, A., Stokes, P. (2016). The Role of Thriving and Training in Merger Success: An Integrative Learning Perspective. Advances in Mergers and Acquisitions. 15 (1). 1-35.
Mcdonald, M.L., Westphal, J.D., Graebner, M.E. (2008). “what do they know? The effects of outside director acquisition experience on firm acquisition performance”. Strategic Management Journal. 29 (11). 1155-1177.
McNaughton, R. B., Osborne, P. and Imrie, B. C. (2002). Market-oriented value creation in service firms. European Journal of Marketing. 36 (9). 990-1002.
Mittal, A., Jain, P.K. (2012). Mergers and Acquisitions Performance System: Integrated Framework for Strategy Formulation and Execution Using Flexible Strategy Game-Card. Global Journal of Flexible Systems Management. 13 (1). 41-56.
Mu, J., Di Benedetto, C. A (2011). Strategic orientations and new product commercialization: mediator, moderator, and Interplay. R&D Management 41 (4). 337-359.
Nahavandi, A. and Malekzadeh, A.R. (1988). Acculturation in mergers and acquisitions. Academy of Management Review. 13 (1). 79-90.
Prebble, R., Anton de Waal, G., and de Groot, C. (2008). Applying multiple perspectives to the design of a commercialization Process. R&D Management. 38 (3). 311-320.
Radfer, R., Pilevari, N., GhaziNoury, S., And Roya Shakeri. (2016). Study of strategic alliance capabilities at the enterprise level; The case of the biopharmaceutical industry. Public Management Research. 8 (27): 45-70. (inPersian)
Ramakrishnan, K. (2010). Mergers in Indian industry: performance and impacting factors, Business Strategy Series. 11 (4). 261-269.
Ranft, A. L. and M. D. Lord, (2002). Acquiring new technologies and capabilities: A grounded model of acquisition implementation. Organization Science. 13 (4). 420-441.
Reza Yaghoubi, R., Yaghoubi, M., Jenny Gibb, S.L. (2016). Mergers and Acquisitions: A Review. Part 1. Studies in Economics and Finance. 33 (1). 1-70.
Sandelowski, M., Barroso, J., & Voils, C. I. (2007). Using qualitative metasummary to synthesize qualitative and quantitative descriptive findings. Research in nursing & health. 30 (1). 99-111.
Schweiger, D.M. (2012). M & A Integration: A Framework for Executives and Managers. McGraw-Hill. New York, NY.
Shakeri, R., Radfar, R. (2017). Antecedents of strategic alliances performance in biopharmaceutical industry: A comprehensive model. Technological Forecasting & Social Change. 122 (1). 289–302.
Sherman, J.D., Berkowitz, D., Souder, W.E. (2005). New Product Development Performance and the Interaction of Cross-Functional Integration and Knowledge Management. Product Development & Management Association. 22 (5). 399–411.
Shi, W., and Prescott, J.E. (2011). Sequence Patterns of Firms’ Acquisition and Alliance Behaviour and their Performance Implications. Journal of Management Studies. 48 (5). 1044- 1070.
Shi, W., Sun, J., Prescott, J.E. (2012). A Temporal Perspective of Merger and Acquisition and Strategic Alliance Initiatives: Review and Future Direction. Journal of Management. 38 (1). 164-209.
Sirower, M. L. and Sahni, S. (2006). Avoiding the synergy trap: practical guidance on M&A decisions for CEOs and boards. Journal of Applied Corporate Finance. 18 (3). 83-95.
Sorrentino, F., Garraffo, F. (2012). Explaining performing R&D through alliances: Implications for the business model of Italian dedicated biotech firms. J Manag Gov. 16 (3). 449-475.
Stahl, G. K. and Voigt, A. (2008). Do cultural differences matter in mergers and acquisitions? A tentative model and examination. Organization Science. 19 (1). 160-176.
Street, C. T. and A. F. Cameron, (2007). External relationships and the small business: A review of small business alliance and network research”. Journal of Small Business Management. 45 (2). 239-266.
Teece, D. J (1986). “Profiting from technological innovation: implication for integra- tion, collaboration, licensing and public policy”. Research Policy. 15 (6). 285-305.
Teerikangas, S., (2012). “Dynamics of acquired firm pre acquisition employee reactions”. Journal of Management. 38 (2). 1–41.
Thornhill, S., Amit, R., (2003). “Learning about failure: Bankruptcy, firm age, and the resource-based view”. Organization Science. 14 (5). 497-509.
Vazquez, E.D.M., Angel Jimenez Martın, j., and Mascarenas, J. (2006). “Strategic alliances as a mechanism for wealth creation in the biopharmaceutical industry: An empirical analysis of the Spanish case”. Journal of commercial biotechnology. 12 (3). 229-236.
Vermeulen, G. A. M. and H. G. Barkema, (2001). “Learning through acquisitions”. Academy of Management Journal. 44 (3). 457-476.
Welter, C., Bosse, D. A., Alvarez, S. A (2013). “The Interaction between Managerial and Technological Capabilities as a Determinant of Company Performance: An Empirical Study of Biotech Firms”. International Journal of Management. 30 (1). Part 2. 272-284
West, P.G., Noel, T.W., (2009). “The impact of knowledge resources on new venture performance”. Journal of Small Business Management. 47 (1). 1-22.
Wiklund, J., Shepherd, D.A. (2009). “The Effectiveness of Alliances and Acquisitions: The Role of Resource Combination Activities”. Entrepreneurship Theory and Practice. 33. (1). 193-212.
Xiong, G., Bharadwaj, S. (2011). “Social Capital of Young Technology Firms and Their IPO Values: The Complementary Role of Relevant Absorptive Capacity”. Journal of Marketing. 75 (6). 87-104.
Zahra, S.A., Nielsen, A.P. (2002). “Sources of capabilities, integration and technology commercialization”. Strategic Management Journal. 23 (5). 377-398.
Zirger, B. J., and M. A. Maidique. (1990). A model of new product development: An empirical test. Management Science. 36 (7). 867-893.
Zollo, M., Meier, D. (2008). What Is M&A Performance? Academy of Management Perspectives. 22 (3). 55-77.
Zollo, M., Reuer, J.J., Singh, H. (2002). Inter organizational Routines and Performance in Strategic Alliances. Organization science. 13 (6). 701-713. | ||
|
آمار تعداد مشاهده مقاله: 143 تعداد دریافت فایل اصل مقاله: 256 |
||